Nowadays, viscoelastic monitoring of coagulation at bedside is used worldwide as it offers the demanded characteristics (5, 6) such as rapid and accurate monitoring of clot formation and destruction, early differential diagnosis of coagulopathy, individualized treatment guidelines following the decision algorithms, good reliability, and very fast response time. There are currently 2 viscoelasticbased coagulation technologies with wide clinical application and sufficient scientific evidence of their effectiveness and excellent results: thromboelastometry (ROTEM®) and thromboelastography (TEG®).
The experience and scientific evidence of employing viscoelastic technologies in the patients with haemorrhagic shock positively increased in the last decade (7) (8) (9) . The objective: to reduce or avoid the transfusion of blood products required to reanimate severe bleeding, without wasting them or overtransfusing the patient, saving on economic resources and acting in the most specific way possible.
The best way to reanimate a severe haemorrhage, in which the risk of coagulopathy is very high, is to consider the best resources and the easiest accessibility to them. It is essential to know the pathophysiology of the procedure that causes bleeding; for example, the acute trauma induced coagulopathy in a severely injured patient, where the viscoelastic approach is described in several studies (10) (11) (12) conducted to highlight the importance of early diagnosis of hyperfibrinolysis, since it is directly related to the increase of mortality. The gold standard to diagnose hyperfibrinolysis is viscoelastic technology. Thus, it is a fundamental tool to diagnose and treat acute traumatic coagulopathy, and also in other conditions such as liver disease (13) , postpartum haemorrhage (14) , or cardiac surgery (15) . The current European guidelines for management of trauma bleeding patients (16) recommend the use of early and repeated monitoring of coagulation, and using a traditional laboratory test (grade 1A) and/or a viscoelastic method (grade 1C).
The broad concept of damage control resuscitation comes from the military setting in the context of the patient with trauma and advocates the management of severe haemorrhage with the application of fixed ratios of transfusion 1:1:1, with fresh frozen plasma as main resuscitation fluid. But even with the last randomized control trial with high scientific evidence (the pragmatic randomized optimal platelet and plasma ratios (PROPPR) Study (17)), a totally favourable conclusion about the use of this approach could not be fully obtained, when trying to compare 1:1:1 to 1:1:2 approaches.
In common clinical practice, depending on the blood products and prothrombotic available drugs it can be acted following the haemostatic protocols and it is always a matter of time and velocity to the physician who leads the resuscitation. There are circumstances in which it is necessary to transfuse very quickly and with great volume, but at the moment when a blood sample can be extracted and analysed in a viscoelastic method, the therapeutic guide marked by the proof of concept (POC) technology is very useful, as the therapeutic efforts are directed to replace only those haemostatic deficient components. In severe active bleedings, the standard coagulation tests are too slow to take fast clinical judgements (18) . In addition, the results obtained from viscoelastic methods are validated in different studies (19) .
The fundamental principle of handling these techniques is that decisions of transfusion should not be strictly made because the test results are outside a numerical range of each parameter defined by the different devices. Decisions will always be taken according to the clinical situation of the patient and according to the availability of treatment options (20, 21) .
The therapeutic decision algorithm based on POC devices should be coupled to the massive transfusion protocol approved in each hospital (22, 23) .The combination of these 2 procedures is what actually brings logic to the resuscitation of a haemorrhagic shock and allows taking advantage of both resources. The transfusion protocol should develop an actuation procedure for the rapid and organized dispensing of blood products from the blood bank. The combination of resources should not be observed as contradictory or incapable of being overlaid on organizational issues. It is an intense multi-disciplinary task that requires an extensive preliminary work of communication so that the protocol of action is consensual and following an ideological order. For this purpose, all medical services involved should participate in the implementation. The development of a protocol that structures the dispensation of hematic products is essential to ensure immediate action if it is necessary in the emergent cases, but it should be followed absolutely by a POC-based treatment algorithm. It requires, as already mentioned, an exhaustive teamwork.
It is certainly difficult to apply the adult-based massive bleeding protocols to children, because the traditional definition of massive transfusion cannot be considered for the paediatric patients. Therefore, estimating blood loss in mL/kg or total blood volume in children should be considered instead of unit counts when considering massive transfusion or bleeding. Adult protocols should be adapted to the paediatric patient, not applying the ratiodriven formulas, but the POC algorithms above all, leaving aside the conventional coagulation tests for an accurate and fast resuscitation (24) . It is assumed that using an algorithm based on fixed ratios of transfusion in children is also the failure of the strategy and there is not sufficient evidence to support this approach at all.
A recent Cochrane revision assessed the benefits and harms of thromboelastography or thromboelastometryguided transfusion in adults and children with severe bleeding (4) . They looked at different outcomes, such as overall mortality and bleeding events, with subgroups and sensitivity analyses, also examining the role of bias to consider the evidence. The study concluded that there is growing evidence that application of POC-guided transfusion strategies may reduce the need for blood products and improve survival in patients with severe bleeding. However, these results are primarily based on trials of elective cardiac surgery involving cardiopulmonary bypass and the level of evidence remains low. Therefore, further evaluation of POC-guided transfusion in acute settings in low risk bias studies is needed.
Several reports suggest that the cost of blood products may rise over time (25) . In the United States, the cost of erythrocyte transfusion exceeds 1.3 billion dollars annually (26) . In the developing countries with limited financial resources, the economic burden of transfusion is even larger due to poorly settled hemovigilance systems. In transfusion medicine, several cost-reduction strategies are introduced (27) . It is suggested that POC-guided transfusion may provide the opportunity to improve quality of care, while reducing the cost thereof. A review study revealed that point-of-care viscoelastic testing is cost-saving and results in reduced amounts of administered blood products without changing the clinical outcome of patients (3) . Another recent survey in patients undergoing cardiac surgery suggested that incorporating viscoelastic testing into transfusion algorithms improved medical outcomes in the presented health economic model, in comparison with standard laboratory tests; despite the higher costs of testing (28) . Optimizing blood usage finally improves the outcome through channelling resources toward other diagnostic and therapeutic initiatives.
Nowadays, there is a wide clinical experience in many medical-surgical disciplines to use POC-guided transfusion, even though the degree of evidence is not strictly desirable to make a unanimous and universal recommendation. For this reason, it should be mandatory for all centres where severe acute haemorrhage is attended, to implement POC technology to develop decision algorithms for haemostatic resuscitation. This could lead to the development of new randomized multicentre clinical trials that reinforce the evidence on the reduction of transfusion of blood components and, above all, the increase in survival of the patients with severe bleeding, both in adults and children.
Once the physician attending the resuscitation of a severe bleeding acquires the routine of combining the initial (maybe empirical, but not necessarily ratio-driven approach) performance with the guidelines of treatment based on point of care haemostatic technology, the results begin to improve, and the resources get optimized (29, 30) . Viscoelastic methods provide a rapid assessment of coag-2
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ulation to support clinical decision-making, generating a growing confidence in these methods, and increased use. By this technology, the general impression is that patients are treated much more specifically, accurately, and costeffectively with improved survival.
